Balyasny Asset Management »

Fulcrum Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 10k 3.57
2024-06-30 $71k 11k 6.20
2024-03-31 $148k 16k 9.44
2023-12-31 $710k 105k 6.75
2023-06-30 $37k 11k 3.30
2022-06-30 $77k 16k 4.91
2021-12-31 $208k 12k 17.73